Gerresheimer at Pharmtech 2011: innovative solutions for health and well-being

Date: 24 November 2011
Source: http://www.worldpressonline.com
Düsseldorf, 17 November 2011 - At Pharmtech in Moscow from 22 to 25 November in Hall 8, Booth B08, Gerresheimer will be presenting innovative solutions for the pharma industry.

Bernd Zeiss, Manager Technical Presales Support in Gerresheimer’s Business Development Unit, will be talking about “New Developments and Trends in the Prefillable Syringe System Segment“ at the Pharmtech Forum from 12:05 to 12:35 on 24 November.

Today, chronically ill people can administer their medication simply and reliably with asthma inhalers and insulin pens. However, even when patients receive an injection from their doctor, use a nasal spray to relieve cold symptoms, take cough medicine or tablets, they also often come into contact with Gerresheimer products because it makes the glass or plastic vials or tablet containers.

The Tubular Glass Division is showcasing a range of prefillable syringes, including its flagship RTF® sterile syringes. Tubular glass is the input material for a comprehensive range of high quality pharmaceutical vials, ampoules and cartridges in numerous filling sizes and design variants.

The Moulded Glass division manufactures high-quality injection, infusion and transfusion bottles as well as dropper and tablet bottles of various types, shapes and sizes in glass categories I, II and III.

 The flagship products being showcased by the Plastic Packaging division are multilayer plastic vials for sensitive parenteral medications. This division has established a leading reputation for its comprehensive range of high quality primary packaging products for liquid and solid medications.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion euros and has around 10,000 employees at 45 locations in Europe, North and South America and Asia.  We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

Press contacts

Jens Kürten

Director Corporate Communication & Marketing

Telephone: +49 211 6181-250

Fax: +49 211 6181-241

E-Mail: j.kuerten@gerresheimer.com

Marion Stolzenwald

Senior Manager Corporate Communication

Telephone: +49 211 6181-246

Fax: +49 211 6181-241

E-Mail: m.stolzenwald@gerresheimer.com

600450 Gerresheimer at Pharmtech 2011: innovative solutions for health and well-being glassonweb.com

See more news about:

Others also read

Proprietary laminate windows collect, store energy; convert it to electricityRIVIERA BEACH, FL – An innovative new patented technology transforms office building windows into "solar farms" and allows these structures to reuse collected energy and become self-sufficient in the event of a power outage.
DALLAS, Texas, December 22, 2011 /PRNewswire/ --ReportsnReports adds new market research report 'Solar Photovoltaic (PV) Power - Global Market Size, Installation Prices, Module Market Shares, Market Segmentation, Regulations and Key Country Analysis to 2020' to its store.
The University of Minnesota's historic Folwell Hall completed three years of extensive renovation, just time for the 2011 academic year.
The development of ESG’s privacy glass product, ESG Polyvision™, has quite literally reached new heights.
We sincerely thank all our members, friends and visitors for being part of GlassOnWeb and its success during 2011.
Michael Gai has been named Vice President of Operations at Glass Doctor, following the recent promotion of Mark Liston to President.

Add new comment